InfuSystems Holdings (INFU)
(Real Time Quote from BATS)
$6.43 USD
+0.01 (0.16%)
Updated Sep 18, 2024 01:02 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
INFU 6.43 +0.01(0.16%)
Will INFU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INFU based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INFU
Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge
INFU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INFU
Craig-Hallum Keeps Their Buy Rating on InfuSystem Holdings, Inc. (INFU)
InfuSystem’s Growth Trajectory and Expansion in Healthcare Services
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
Sanara MedTech and InfuSystem execute U.S. distribution agreement